home / stock / podd / podd news


PODD News and Press, Insulet Corporation

Stock Information

Company Name: Insulet Corporation
Stock Symbol: PODD
Market: NASDAQ
Website: insulet.com

Menu

PODD PODD Quote PODD Short PODD News PODD Articles PODD Message Board
Get PODD Alerts

News, Short Squeeze, Breakout and More Instantly...

PODD - Glaukos cut as Citi reviews U.S. MedTechs

2024-07-10 12:52:04 ET More on Glaukos, Intuitive Surgical, etc. Glaukos Stock: Still Unproven Whether A New Bull Market Has Begun Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here Intuitive Surgical: Hope For A Resurgence In Operational Leve...

PODD - Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the second quarter of 2024 on August 8, 2024 after the close of the financial...

PODD - ClearBridge Growth Strategy Q2 2024 Commentary

2024-07-06 07:45:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. During the quarter, a ...

PODD - Insulet tops S&P 500 growth chart for Q2 as it gains market share in the diabetes space

2024-06-29 11:35:00 ET The Health Care Select Sector SPDR Fund ETF ( NYSEARCA: XLV ), tracking the healthcare companies under S&P 500, rose 0.11% in the second quarter of 2024, lagging behind the broader S&P 500 index which rose 4.30%.... Read the full article on Seeki...

PODD - Tandem Diabetes, DexCom see weakness following ADA conference

2024-06-24 12:06:59 ET More on DexCom, Tandem Diabetes Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here Dexcom: Positive Catalysts Ahead To Support Growth DexCom: Attractive Discount After Strong Earnings Results Tandem Diabetes Care...

PODD - Insulet's SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

Largest, longest, and most racially diverse study of automated insulin delivery (AID) conducted in people with type 2 diabetes to date Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® bra...

PODD - Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

Following a successful limited market release, the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) is now fully available with Dexcom G6 and Abbott FreeStyle Libre 2 Plus in these countries Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tub...

PODD - Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

Omnipod 5, the world’s first tubeless automated insulin delivery (AID) system integrated with Dexcom G6, is now available in France Full commercial launch of Omnipod 5 with Dexcom G7 integration has commenced in the U.S. Omnipod 5 App for iPhone begins limited marke...

PODD - (PODD) Trading Report

2024-06-14 00:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PODD - Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023

2024-06-11 16:27:23 ET Summary Insulet Corporation saw a significant drop in stock price in 2023 due to concerns over the impact of GLP-1 weight loss drugs on the insulin pump industry. These fears seem to be largely overblown, however, meaning that Insulet is arguably still tradi...

Next 10